Press releases
- GSK and Vir Biotechnology announce the start of the EMA rolling review of VIR-7831 (sotrovimab) for the early treatment of COVID-19
- ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV
- GSK students take on the role of engineers during GSK Science in the Summer™ in partnership with The Franklin Institute
Tweets from GSK US
-
GSKUS @GSKUS
#DYK some people don’t recognize when they’re experiencing uncontrolled #asthma symptoms? If persistent asthma attacks continue despite treatment, there may be more to the story. Learn more about the condition this #AsthmaAwarenessMonth.
about 16 hours ago -
GSKUS @GSKUS
#DYK the 8th of May is #WorldOvarianCancerDay? Learn more about the signs & symptoms of #OvarianCancer 👇 and learn about the disease here: gsk.to/3b21zZOHD#WOCD20212#PowerfulTogethereoM
about 19 hours ago -
GSKUS @GSKUS
Show your support for people living with #lupus and #lupusnephritis by sharing with the world #whyitattoo! Learn more. 👉gsk.to/3upC6Ru3#LupusAwarenessMonthh
about 19 hours ago
s
